Viewing Study NCT06579300



Ignite Creation Date: 2024-10-26 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 3:39 PM
Study NCT ID: NCT06579300
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-28

Brief Title: A Study to Assess Multiple Ascending Dose Drug-Drug Interaction and Asian Pharmacokinetic Study of ABBV-1088
Sponsor: None
Organization: None

Study Overview

Official Title: A Phase 1 Multiple Ascending Dose Drug-Drug Interaction and Asian Pharmacokinetic Study of ABBV-1088
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will assess the safety tolerability and pharmacokinetics of ABBV-1088 in healthy adult Western Han-Chinese and Japanese participants This study will also assess drug-drug interaction between itraconazole and ABBV-1088 in healthy adult Western participants
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None